Navigation Links
Merrimack Pharmaceuticals' Phase 1 Research Supports MM-121 Potential For Investigation As Combination With Chemotherapy In Patients With Advanced Solid Tumors
Date:6/4/2013

.pdf">website.  

About Merrimack Pharmaceuticals, Inc.
Merrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. Merrimack applies its systems biology-based approach to biomedical research throughout the research and development process. Merrimack currently has six oncology therapeutics in clinical development.

Forward-Looking Statement
To the extent that statements contained in this press release are not descriptions of historical facts, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements include any statements about Merrimack's strategy, future operations, future financial position and future expectations and plans and prospects for Merrimack, and any other statements containing the words "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," and similar expressions. In this press release, Merrimack's forward-looking statements include statements about the potential effectiveness of its drug candidates in new indications and its ability to translate clinical data into future clinical success. Such forward-looking statements involve substantial risks and uncertainties that could cause Merrimack's clinical development programs, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in the initiation of future clinical trials, availability of data from ongoing clinical trials, expectations for regulatory approvals and other matters that could affect the availability
'/>"/>

SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Merrimack Pharmaceuticals Preclinical Research Shows MM-111 Restores Sensitivity To Chemotherapy And HER2-targeted Treatment In Gastric Cancer Model
2. Merrimack Pharmaceuticals Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
3. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
4. Merrimack Pharmaceuticals To Present Phase I Data On MM-302 And Preclinical Data On Companion Diagnostics Both For The Treatment Of HER2-Positive Breast Cancer
5. Isis Pharmaceuticals Reports Encouraging Data on ISIS-STAT3rx in Patients With Cancer
6. Ferring Pharmaceuticals Inc. Announces $1M Donation to the Alliance for Fertility Preservation, a Newly Formed Charitable Organization
7. Ampio Pharmaceuticals Provides Clinical Updates
8. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
9. Auxilium Pharmaceuticals, Inc. To Present At The Jefferies 2013 Healthcare Conference
10. Isis Pharmaceuticals Announces Exercise of Underwriters Option to Purchase Additional Shares
11. Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- "Fatty Liver Disease Global Clinical Trials Review, H2, ... trial scenario. This report provides elemental information and data ... Disease . It includes an overview of the trial ... of trial conduction across the globe. The databook offers ... phase, trial status, prominence of the sponsors and also ...
(Date:8/27/2014)... WARSAW, Ind. , Aug. 27, 2014  Zimmer ... in musculoskeletal care, announced that it will be participating ... the Grand Hyatt in New York, New ... David Dvorak , President and CEO of Zimmer, will ... Binder , President and CEO of Biomet, will join ...
(Date:8/27/2014)... , NEW YORK and LONDON ... provider of market research solutions, MarketResearch.com is pleased ... its Kalorama Information Medical Devices Knowledge Center. ... easy-to-use platform hosting the latest market research in ... entire library of reports from industry expert, Kalorama ...
Breaking Medicine Technology:Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 2Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 3Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 4Fatty Liver Disease Therapeutics Clinical Trials Market Review 2014 Analysis Report Available at MarketOptimizer.org 5MarketResearch.com: New Medical Devices Research Reports Added to Kalorama Information Knowledge Center 2MarketResearch.com: New Medical Devices Research Reports Added to Kalorama Information Knowledge Center 3
... SEATTLE, May 2, 2011 CMC Biologics, a ... Copenhagen, Denmark and Seattle, Washington USA, announced today ... at its Chief Executive Officer. CMC Biologics, a ... world class, fully integrated, biopharmaceutical process development and ...
... SAN DIEGO, May 2, 2011 Volcano Corporation (NASDAQ: ... of precision intravascular diagnosis and therapy guidance tools designed ... disease, said today that it will be participating in ... May 10. The presentation by John Dahldorf, ...
Cached Medicine Technology:CMC Biologics Announces Appointment of New CEO 2
(Date:8/27/2014)... Jaha was founded with a vision that fitness is ... industry’s most affordable fitness tracker together with an app to ... Jaha plans to announce their latest concept, an ... locate, challenge and motivate. , The Jaha Kickstarter ... support and to raise awareness on this new concept for ...
(Date:8/27/2014)... August 27, 2014 Nava Beauty Store and ... to all patrons from those seeking luxury care products to ... They carry high end luxurious brands like Valmont and Elemis ... also sells brands like Dermalogica and Bliss to provide easy ... customers. They also offer purely organic skin care products such ...
(Date:8/27/2014)... Many patients believe mental illness is ... has a mortality rate of about 15%. The ... less, though it's offset by an alarming homicide rate ... to properly treat and manage symptoms of mental illnesses ... taken as directed. Missed dosages or cutting pills ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Sugar ... climatic conditions and fluctuations in global supply and demand, ... past five years. The industry derives a large share ... subject to global market dynamics, with supply and prices ... and India. A strong Australian dollar for the majority ...
(Date:8/27/2014)... Mass., (PRWEB) August 27, 2014 BCC ... ADVANCED ORTHOPEDIC TECHNOLOGIES, IMPLANTS AND REGENERATIVE PRODUCTS , ... to increase from $36.4 billion by 2014-end to $42.2 ... (CAGR) of 3% from 2014 to 2019. New technologies ... major driving forces within the market. , While there ...
Breaking Medicine News(10 mins):Health News:Jaha, Inc. The Most Affordable Fitness Band in the Market Released on Kickstarter 2Health News:Nava Beauty Store Announce Grand Opening in Great Neck, New York 2Health News:MedicationDiscountCard.com now Makes Brintellix and Mental Illness Medications More Affordable with Discount Cards 2Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Sugar Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 3
... themselves and their partners, organizers say , FRIDAY, June ... of HIV testing is among the goals of the ... To mark the day, thousands of HIV testing sites, ... fairs, provide community and media outreach, host special testing-related ...
... Trends, News and Insights to Eye Care Practitioners Nationwide , ... & Lomb announces the launch of the Center for Patient ... to unbiased industry information, trends, market research, and insights for ... Patient Insights, main goal is to deliver news and insights ...
... CVS Caremark (NYSE: CVS ) is proud ... nation,s leading corporations for innovative programs promoting a healthy workplace and ... about their own health and well-being. , , ... , CVS Caremark received the Best Employers for Healthy Lifestyles ...
... Get ... Centers for Disease Control and Prevention (CDC) estimates that one out of five people living with ... is an opportunity for people nationwide to gain knowledge to take control of their health and ... Ft. Myers, FL (PRWEB) ...
... ... the nation,s third largest nationally recognized physician multi-specialty certifying organization , has formed ... ... American Board of Physician Specialties (ABPS) today announced the formation of the American Board ...
... 25 Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: ... request of the Food and Drug Administration, today arrived ... The seizure also included ingredients held at these same ... facility, completed in May 2009, found unresolved violations of ...
Cached Medicine News:Health News:Bausch & Lomb Announces New Center for Patient Insights 2Health News:CVS Caremark Recognized with Gold Award from National Business Group on Health for Promoting Healthy Lifestyles for Employees 2Health News:CVS Caremark Recognized with Gold Award from National Business Group on Health for Promoting Healthy Lifestyles for Employees 3Health News:JustGetTested.com Offers Fast, Confidential HIV Testing to Mark National HIV Testing Day 2Health News:American Board of Family Medicine Obstetrics Formed 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Action 2
... The new line of Myoquick systemplus Multi-channels Evoked ... of Micromed in the neurophysiology field and shows ... Multi-channel EP unit adopt the 32 channels headbox ... of the ISA 100x EP family headboxes: ISA ...
Solid steel construction for lifelong quality. Strong, smooth and quiet electro-mechanical up/down movement. Dual castor, locking wheels for use on carpet or tile flooring. Easy cleaning, deluxe lami...
If you presently have an exam chair that is separate from the instrument stand, we can solve your access problem with a Burton 1200 Chair-exchanger...
... A marvel of engineering and innovative ... precision, unparalleled quality and masterful workmanship. At ... bring the ophthalmic industry a truly innovative ... From product design to quality construction and ...
Medicine Products: